Genomed Spólka Akcyjna (WSE:GEN)

Poland · Delayed Price · Currency is PLN

33.00

-0.20 (-0.60%)

At close: Sep 4, 2026

Genomed Spólka Akcyjna Financials Overview

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	30.64	29.12	23.01	22.48	20.46	19.89
Revenue Growth	21.90%	26.58%	2.34%	9.88%	2.84%	6.08%
Gross Profit	20.83	19.33	14.49	14.11	12.18	12.55
Operating Income	4.24	4.08	1.2	1.24	0.36	1.34
Net Income	3.51	3.4	1.11	0.93	0.34	1.24
Earnings Per Share	2.65	2.57	0.84	0.70	0.26	0.94
EPS Growth	-	207.58%	19.32%	174.07%	-72.70%	200.29%

Revenue by Segment

Fiscal Year	TTM	FY 2025
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025
Sales of Products	30	28.52
Sales of Goods and Materials	0.64	0.6
Total	30.64	29.12

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	7.33	6.1	5.24	5.26	3.49	4.86
Total Debt	-	-	-	-	-	-
Net Cash (Debt)	7.33	6.1	5.24	5.26	3.49	4.86
Net Cash Growth	-	16.37%	-0.37%	50.81%	-28.21%	34.03%
Net Cash Per Share	5.54	4.62	3.97	3.98	2.64	3.68

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	4.72	3.23	1.64	1.97	-0.36	2.21
Capital Expenditures	-0.26	-1.13	-1.67	-0.2	-0.25	-0.52
Free Cash Flow	4.46	2.11	-0.03	1.76	-0.6	1.7
Free Cash Flow Growth	242.90%	-	-	-	-	91.94%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	67.99%	66.36%	63.00%	62.75%	59.52%	63.09%
Operating Margin	13.83%	14.01%	5.23%	5.53%	1.74%	6.72%
Pretax Margin	13.95%	13.99%	5.27%	4.68%	1.80%	6.70%
Profit Margin	11.44%	11.67%	4.80%	4.12%	1.65%	6.22%
FCF Margin	14.55%	7.24%	-0.12%	7.84%	-2.94%	8.52%

Dividends

Fiscal Year	Current	FY 2025
Period Ending	Sep '26 Sep 5, 2026	Dec '25 Dec 31, 2025
Dividend Per Share	1.500	1.500
Dividend Per Share Growth	0%	-
Dividend Yield	4.46%	6.54%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	12.44	9.41	31.80	42.51	132.93	36.50
P/FCF Ratio	9.78	15.17	-	22.33	-	26.65
PS Ratio	1.42	1.10	1.53	1.75	2.20	2.27